Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of CNGB1 Retinitis Pigmentosa and Allied Hereditary Disorders

NCT04639635 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04639635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of CNGB1 Retinitis Pigmentosa and Allied Hereditary Disorders
Lead sponsor
Columbia University
Phase
Observational
Overall status
Suspended
Start date
March 14, 2019
Completion date
February 28, 2027
Enrollment
20 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa associated with cngb1 mutations